186 related articles for article (PubMed ID: 227957)
1. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
Mills BJ; Beebe DP; Cooper NR
J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
5. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.
Mills BJ; Cooper NR
J Immunol; 1978 Oct; 121(4):1549-57. PubMed ID: 212482
[No Abstract] [Full Text] [Related]
6. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
Lefrancois L; Lyles DS
J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
[TBL] [Abstract][Full Text] [Related]
7. Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum.
Pipperger L; Koske I; Wild N; Müllauer B; Krenn D; Stoiber H; Wollmann G; Kimpel J; von Laer D; Bánki Z
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243134
[TBL] [Abstract][Full Text] [Related]
8. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to vesicular stomatitis virus in cattle in an enzootic region of Mexico.
Hernández De Anda J; Salman MD; Webb PA; Keefe TJ; Arregín Arévalo A; Mason J
Am J Vet Res; 1992 Apr; 53(4):440-3. PubMed ID: 1316723
[TBL] [Abstract][Full Text] [Related]
11. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
12. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
Závadová Z; Závada J
Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
[TBL] [Abstract][Full Text] [Related]
13. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
[TBL] [Abstract][Full Text] [Related]
14. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus.
Charan S; Zinkernagel RM
J Immunol; 1986 Apr; 136(8):3057-61. PubMed ID: 3007610
[TBL] [Abstract][Full Text] [Related]
15. An enzyme-linked immunosorbent assay for the detection of bovine antibodies to vesicular stomatitis virus.
Workman T; Shen D; Woodard L; Yilma T
Am J Vet Res; 1986 Jul; 47(7):1507-12. PubMed ID: 3017162
[TBL] [Abstract][Full Text] [Related]
16. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
17. Serum neutralizing antibody titers in dairy cattle administered an inactivated vesicular stomatitis virus vaccine.
Gearhart MA; Webb PA; Knight AP; Salman MD; Smith JA; Erickson GA
J Am Vet Med Assoc; 1987 Oct; 191(7):819-22. PubMed ID: 2824413
[TBL] [Abstract][Full Text] [Related]
18. Cross-neutralization between vesicular stomatitis virus type Indiana and Chandipura virus.
Dragúnová J; Závada J
Acta Virol; 1979 Jul; 23(4):319-28. PubMed ID: 40419
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
